The GLP-1 Receptor Agonist Liraglutide Improves Autophagy Impairment in the Diabetic Heart

被引：0
|
作者：
Bugyei-Twum, Antoinette [1 ]
Switzer, Jennifer [1 ]
Singh, Krishna K. [1 ]
Connelly, Kim A. [1 ]
机构：
[1] St Michaels Hosp, Toronto, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2017年 / 37卷
关键词：
Autophagy; Diabetes (Type II);
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
368
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Urva, Shweta
    Quinlan, Tonya
    Landry, John
    Martin, Jennifer
    Loghin, Corina
    CLINICAL PHARMACOKINETICS, 2021, 60 (08) : 1049 - 1059
  • [42] Effect of the GLP-1 Receptor Agonist, Liraglutide as an Adjunct to Insulin Treatment in a Rodent Model of Type 1 Diabetes
    Meek, Thomas H.
    Kumar, Monica
    Matsen, Miles E.
    Fischer, Jonathan D.
    Taborsky, Gerald J., Jr.
    Schwartz, Michael W.
    Morton, Gregory J.
    DIABETES, 2013, 62 : A733 - A733
  • [43] Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Shweta Urva
    Tonya Quinlan
    John Landry
    Jennifer Martin
    Corina Loghin
    Clinical Pharmacokinetics, 2021, 60 : 1049 - 1059
  • [44] Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Shweta Urva
    Tonya Quinlan
    John Landry
    Xiaosu Ma
    Jennifer A. Martin
    Charles T. Benson
    Clinical Pharmacokinetics, 2022, 61 : 1057 - 1067
  • [45] Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Urva, Shweta
    Quinlan, Tonya
    Landry, John
    Ma, Xiaosu
    Martin, Jennifer A.
    Benson, Charles T.
    CLINICAL PHARMACOKINETICS, 2022, 61 (07) : 1057 - 1067
  • [46] Liraglutide Improves Periodontitis by the Anti-inflammatory Activities of GLP-1
    Sawada, Noritaka
    Naruse, Keiko
    Matsubara, Tatsuaki
    Nakamura, Nobuhisa
    Miyabe, Megumi
    Ito, Mizuho
    Suzuki, Yuki
    Adachi, Kei
    Kobayashi, Shuichiro
    Kikuchi, Takeshi
    Mitani, Akio
    Toriumi, Taku
    Mizutani, Makoto
    Honda, Masaki
    DIABETES, 2019, 68
  • [47] A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
    Al-Zamel, Noura
    Al-Sabah, Suleiman
    Luqmani, Yunus
    Adi, Lobna
    Chacko, Siby
    Schneider, Tom Dario
    Krasel, Cornelius
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [48] The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy
    Varadhan, Lakshminarayanan
    Humphreys, Tracy
    Walker, Adrian B.
    Varughese, George I.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (03) : E37 - E39
  • [49] Existing and emerging GLP-1 receptor agonist therapy: Ramifications for diabetic retinopathy screening
    Varughese, George Iype
    Jacob, Sarita
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2024, 54 (02): : 170 - 173
  • [50] Cardiovascular benefits of GLP-1 (liraglutide) treatment in experimental arterial hypertension are mediated by the endothelial GLP-1 receptor
    Steven, S.
    Helmstaedter, J.
    Filippou, K.
    Pawelke, F.
    Katie, F.
    Vujacic-Mirski, K.
    Kalinovic, S. S.
    Kroeller-Schoen, S.
    Oelze, M.
    Munzel, T.
    Daiber, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2699 - 2699
12345